MG1113, a specific anti-tissue factor pathway inhibitor antibody, rebalances the coagulation system and promotes hemostasis in hemophilia.

When blood losses for different administration doses were compared, hemoglobin values showed a decreasing trend as the administration dose of MG1113 was increased (Figure 6A ).

also in 47,180 other papers